Unique cytokine signature in the plasma of patients with fibromyalgia

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Sturgill, Jamie ^a   McGee, Elizabeth ^a,b   Menzies, Victoria ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR; IL4 PROTEIN, HUMAN; IL5 PROTEIN, HUMAN; INTERLEUKIN-13, HUMAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; DIAGNOSTIC KIT; FEMALE; FIBROMYALGIA; HUMAN; IMMUNE DYSREGULATION; IMMUNOPATHOGENESIS; INFLAMMATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SECONDARY ANALYSIS; TH1 CELL; ADOLESCENT; BLACK PERSON; BLOOD; CAUCASIAN; ETHNOLOGY; IMMUNOLOGY; MIDDLE AGED; TH1 TH2 BALANCE;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBROMYALGIA; HUMANS; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; MIDDLE AGED; TH1-TH2 BALANCE;

EID: 84897492785     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/938576     Document Type: Article

References (32)

1. National Fibromyalgia Association,. Fibromyalgia Fact Sheet, 2012, http://fmaware.org/site/PageServerc145.html?pagename=fibromyalgia-fmFactSheet
2. Jones K. D., Ross R. L., Adams D. G., Bennett R. M., Fibromyalgia: rational management in primary care. Clinician Reviews 2006 16 5 42 48
3. Wallace D. J., Is there a role for cytokine based therapies in fibromyalgia. Current Pharmaceutical Design 2006 12 1 17 22 2-s2.0-33644859724 10.2174/138161206775193208
4. Mease P. J., Arnold L. M., Bennett R., Boonen A., Buskila D., Carville S., Chappell A., Choy E., Clauw D., Dadabhoy D., Gendreau M., Goldenberg D., Littlejohn G., Martin S., Perera P., Russell I. J., Simon L., Spaeth M., Williams D., Crofford L., Fibromyalgia syndrome. Journal of Rheumatology 2007 34 6 1415 1425 2-s2.0-34250176930 (Pubitemid 46898129)
5. Breen E. C., Reynolds S. M., Cox C., Jacobson L. P., Magpantay L., Mulder C. B., Dibben O., Margolick J. B., Bream J. H., Sambrano E., Martínez-Maza O., Sinclair E., Borrow P., Landay A. L., Rinaldo C. R., Norris P. J., Multisite comparison of high-sensitivity multiplex cytokine assays. Clinical and Vaccine Immunology 2011 18 8 1229 1242 2-s2.0-79961117116 10.1128/CVI.05032-11
6. Üçeyler N., Valenza R., Stock M., Schedel R., Sprotte G., Sommer C., Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis and Rheumatism 2006 54 8 2656 2664 2-s2.0-33747006154 10.1002/art.22026 (Pubitemid 44205028)
7. Menzies V., Lyon D. E., Integrated review of the association of cytokines with fibromyalgia and fibromyalgia core symptoms. Biological Research for Nursing 2010 11 4 387 394 2-s2.0-77949825492 10.1177/1099800409348328
8. Menzies V., Lyon D. E., Elswick R. K. Jr., McCain N. L., Gray D. P., Effects of guided imagery on biobehavioral factors in women with fibromyalgia. Journal of Behavioral Medicine 2014 37 1 70 80 10.1007/s10865-012-9464-7
9. Üçeyler N., Hauser W., Sommer C., Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskeletal Disorders 2011 12 article 245 10.1186/1471-2474-12-245
10. Bote M. E., Garcia J. J., Hinchado M. D., Ortega E., Inflammatory/stress feedback dysregulation in women with fibromyalgia. Neuroimmunomodulation 2012 19 6 343 351 10.1159/000341664
11. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L., Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology 1986 136 7 2348 2357 2-s2.0-0022640843 (Pubitemid 16136806)
12. Kim Y. K., Myint A. M., Lee B. H., Han C. S., Lee H. J., Kim D. J., Leonard B. E., Th1, Th2 and Th3 cytokine alteration in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004 28 7 1129 1134 2-s2.0-10944266569 10.1016/j.pnpbp.2004.05.047 (Pubitemid 40017629)
13. Yoon H. K., Kim Y. K., Lee H. J., Kwon D. Y., Kim L., Role of cytokines in atypical depression. Nordic Journal of Psychiatry 2012 66 3 183 188 10.3109/08039488.2011.611894
14. Austin P. J., Moalem-Taylor G., The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. Journal of Neuroimmunology 2010 229 1-2 26 50 2-s2.0-78650309320 10.1016/j.jneuroim.2010.08.013
15. Wolfe F., Smythe H. A., Yunus M. B., Bennett R. M., Bombardier C., Goldenberg D. L., Tugwell P., Campbell S. M., Abeles M., Clark P., Fam A. G., Farber S. J., Fiechtner J. J., Franklin C. M., Gatter R. A., Hamaty D., Lessard J., Lichtbroun A. S., Masi A. T., The American College of Rheumatology 1990. Criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis and Rheumatism 1990 33 2 160 172 2-s2.0-0025266660 (Pubitemid 20098653)
16. Wolfe F., Clauw D. J., Fitzcharles M. A., Goldenberg D. L., Häuser W., Katz R. S., Mease P., Russell A. S., Russell I. J., Winfield J. B., Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. Journal of Rheumatology 2011 38 6 1113 1122 2-s2.0-79957809749 10.3899/jrheum.100594
17. Cohen S., Williamson G., Perceived Stress in a Probability Sample of the United States 1988 Newbury Park, Calif, USA Sage
18. Cleeland C. S., Chapman C. R., Loeser J. D., Measurement of pain by subjective report. Issues in Pain Measurement 1989 12 New York Raven Press 391 403 Advances in Pain Research and Therapy
19. M. D. Anderson Cancer Center Pain Research Group,. Brief Pain Inventory, http://www3.mdanderson.org/depts/prg/bpi.htm
20. Mendoza T. R., Wang X. S., Cleeland C. S., Morrissey M., Johnson B. A., Wendt J. K., Huber S. L., The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 1999 85 5 1186 1196 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N (Pubitemid 29115600)
21. Radloff L. S., The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977 1 3 385 401 10.1177/014662167700100306
22. Lambeck A. J., Crijns A. P., Leffers N., Sluiter W. J., Ten Hoor K. A., Braid M., van der Zee A. G. J., Daemen T., Nijman H. W., Kast W. M., Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: a potential role for interleukin 7. Clinical Cancer Research 2007 13 8 2385 2391 2-s2.0-34247877774 10.1158/1078-0432.CCR-06-1828 (Pubitemid 46698588)
23. Kadetoff D., Lampa J., Westman M., Andersson M., Kosek E., Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. Journal of Neuroimmunology 2012 242 1-2 33 38 2-s2.0-84856769108 10.1016/j.jneuroim.2011.10.013
24. Fletcher M. A., Zeng X. R., Barnes Z., Levis S., Klimas N. G., Plasma cytokines in women with chronic fatigue syndrome. Journal of Translational Medicine 2009 7 article 96 10.1186/1479-5876-7-96
25. Wong H. L., Pfeiffer R. M., Fears T. R., Vermeulen R., Ji S., Rabkin C. S., Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiology Biomarkers and Prevention 2008 17 12 3450 3456 2-s2.0-57449084708 10.1158/1055-9965.EPI-08-0311
26. Sadeghi M., Daniel V., Naujokat C., Weimer R., Opelz G., Strikingly higher interleukin (IL)-1 α IL-1 β and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)- α transforming growth factor (TGF)- β 2 and interferon IFN- γ urine levels in healthy females compared to healthy males: protection against urinary tract injury? Clinical and Experimental Immunology 2005 142 2 312 317 2-s2.0-27644465185 10.1111/j.1365-2249.2005.02924.x (Pubitemid 41565247)
27. Corcos M., Guilbaud O., Paterniti S., Curt F., Hjalmarsson L., Moussa M., Chambry J., Loas G., Chaouat G., Jeammet P., Correlation between serum levels of interleukin-4 and alexithymia scores in healthy female subjects: preliminary findings. Psychoneuroendocrinology 2004 29 5 686 691 2-s2.0-12144289773 10.1016/S0306-4530(03)00087-8 (Pubitemid 38369169)
28. Xu Z., Chen Y., Determination of serum interleukin-13 and nerve growth factor in patients with systemic lupus erythematosus and clinical significance. Journal of Huazhong University of Science and Technology: Medical Sciences 2005 25 3 360 361 2-s2.0-34547506744
29. Togo F., Natelson B. H., Adler G. K., Ottenweller J. E., Goldenberg D. L., Struzik Z. R., Yamamoto Y., Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia. Experimental Biology and Medicine 2009 234 2 232 240 2-s2.0-60549107029 10.3181/0808-RM-254
30. Zhang Z., Cherryholmes G., Mao A., Marek C., Longmate J., Kalos M., St. Amand R. P., Shively J. E., High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Experimental Biology and Medicine 2008 233 9 1171 1180 2-s2.0-52649108036 10.3181/0712-RM-328
31. Üçeyler N., Topuzoǧlu T., Schiesser P., Hahnenkamp S., Sommer C., IL-4 deficiency is associated with mechanical hypersensitivity in mice. PLoS ONE 2011 6 12 e28205 10.1371/journal.pone.0028205
32. Karam M. C., Merckbawi R., El-Kouba J. E., Bazzi S. I., Bodman-Smith K. B., In Leishmania major-induced inflammation, interleukin-13 reduces hyperalgesia, down-regulates IL-1 β and up-regulates IL-6 in an IL-4 independent mechanism. Experimental Parasitology 2013 134 2 200 205 10.1016/j.exppara.2013.02.005